Mercury Laboratories Ltd — Board Meeting, 14-05-2025: Board Meeting

Mercury Laboratories has announced a board meeting at which it approved the financial results for the quarter and half-year ended March 31, 2025, with the auditors expressing an unmodified opinion. The Board has proposed a final dividend of 35% (Rs 3.50 per share) pending shareholder approval. Mr. Sanjay Patel has been appointed as an Additional Non-Executive Independent Director and Chairman, while Mr. Rajendra Shah has been recommended for re-appointment as Managing Director for three years from April 1, 2026, subject to shareholder approval. Mr. Bharat Mehta retired as Independent Director after completing his term. New appointments include a Secretarial Auditor for five years, an Internal Auditor, and a Cost Auditor for FY2025-26. The company continues to operate in the pharmaceutical products segment. Total revenue for the year was Rs 75.10 Cr with net profit at Rs 3.14 Cr.